India's drug regulator is cracking down on the easy availability of GLP-1 weight-loss drugs following nationwide raids. Inspections revealed significant gaps in how these prescription medicines are sold and promoted, with concerns over sales without prescriptions and inadequate medical oversight. Authorities are intensifying enforcement to curb misuse and ensure these drugs are only dispensed under strict medical supervision.